<DOC>
	<DOCNO>NCT01176773</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness Juvéderm® Ultra Lip Injectable Gel lip enhancement .</brief_summary>
	<brief_title>Safety Effectiveness Juvéderm® Ultra Lip Injectable Gel Lip Enhancement</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>18 year age old Desire enhancement his/her vermilion border and/or vermilion mucosa Cupid 's bow , philtral column , perioral line , oral commissure may also treat Have baseline score Minimal Mild , assess Investigator accord 4point Lip Fullness Scale ( Minimal , Mild , Moderate , Marked ) Have establish realistic Lip Fullness treatment goal Investigator agree achievable Have undergone cosmetic facial , lip perioral procedure [ e.g. , facelift surgery may alter appearance lip perioral area ( laser , photomodulation , intense pulse light , radio frequency , dermabrasion , moderate great depth chemical peel , ablative procedure ) , tissue augmentation dermal filler fat injection , mesotherapy ] anywhere face neck , BOTOX® Cosmetic injection low face ( orbital rim ) , within 6 month prior entry study planning undergo procedure time study . Note : Prior treatment Hyaluronic Acid filler and/or collage allow , provide treatment administer less 6 month prior study entry Have ever receive semipermanent filler permanent facial implant ( e.g. , calcium hydroxylapatite , Lpolylactic acid , PMMA , silicone , ePTFE ) anywhere lips , plan implant product time study Have history anaphylaxis , multiple severe allergy , atopy , allergy local anaesthesia agent , hyaluronic acid product Streptococcal protein , plan undergo desensitization therapy term study Are pregnant , lactating , plan become pregnant time study Have receive investigational product within 30 day prior study enrollment planning participate another investigation course study Have condition situation , Investigator 's opinion , may put subject significant risk , may confound study result , may interfere significantly subject 's participation study Have history currently suffer autoimmune disease Have history treatment interferon chronic hepatitis C Be ongoing regimen anticoagulation therapy ( e.g. , warfarin ) take NSAIDs ( e.g . aspirin , ibuprofen ) substances known increase coagulation time ( e.g . herbal supplement garlic Gingko Biloba ) within 10 day undergo study device injection . Note : Study device injection may delay necessary accommodate 10day wash period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>